Brief: Newron Completes Patient Enrollment In Pivotal STARS Study

Newron Pharmaceuticals SpA

01/02/2019 06:05

Feb 1 (Reuters) - NEWRON PHARMACEUTICALS SPA  NWRN.S :
    * COMPLETES PATIENT ENROLLMENT IN PIVOTAL STARS STUDY
    * TOP LINE RESULTS EXPECTED IN Q4 2019
    * POSITIVE STUDY RESULTS MAY LEAD TO APPROVAL OF FIRST DRUG
TO
BENEFIT A KEY SYMPTOM OF RETT SYNDROME, A SEVERE
NEURO-DEVELOPMENTAL ORPHAN DISEASE

Source text for Eikon:  ID:nTEN6nq9ba 
Further company coverage:  NWRN.S 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))